Synthesis and Antiparasitic Activity of New Trithiolato-Bridged Dinuclear Ruthenium(II)-arene-carbohydrate Conjugates

被引:4
作者
Holzer, Isabelle [1 ]
Desiatkina, Oksana [1 ]
Anghel, Nicoleta [2 ]
Johns, Serena K. K. [1 ,3 ]
Boubaker, Ghalia [2 ]
Hemphill, Andrew [2 ]
Furrer, Julien [1 ]
Paunescu, Emilia [1 ]
机构
[1] Univ Bern, Dept Chem Biochem & Pharmaceut Sci, Freie Str 3, CH-3012 Bern, Switzerland
[2] Univ Bern, Inst Parasitol, Vetsuisse Fac, Langgass Str 122, CH-3012 Bern, Switzerland
[3] Cardiff Univ, Sch Chem, Pk Pl, Cardiff CF103AT, Wales
来源
MOLECULES | 2023年 / 28卷 / 02期
关键词
ruthenium(II)-arene complexes; bioorganometallic; carbohydrates; CuAAC reactions; antiparasitic; Toxoplasma gondii; human foreskin fibroblasts; auxotrophy; toxicity; ARENE RUTHENIUM(II) COMPLEXES; VITRO ANTICANCER ACTIVITY; IN-VITRO; TOXOPLASMA-GONDII; METAL-COMPLEXES; GLUCOSE TRANSPORTERS; BIOLOGICAL-ACTIVITY; NEOSPORA-CANINUM; CLICK CHEMISTRY; HUMAN OVARIAN;
D O I
10.3390/molecules28020902
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Eight novel carbohydrate-tethered trithiolato dinuclear ruthenium(II)-arene complexes were synthesized using CuAAC 'click' (Cu(I)-catalyzed azide-alkyne cycloaddition) reactions, and there in vitro activity against transgenic T. gondii tachyzoites constitutively expressing beta-galactosidase (T. gondii beta-gal) and in non-infected human foreskin fibroblasts, HFF, was determined at 0.1 and 1 mu M. When evaluated at 1 mu M, seven diruthenium-carbohydrate conjugates strongly impaired parasite proliferation by >90%, while HFF viability was retained at 50% or more, and they were further subjected to the half-maximal inhibitory concentration (IC50) measurement on T. gondii beta-gal. Results revealed that the biological activity of the hybrids was influenced both by the nature of the carbohydrate (glucose vs. galactose) appended on ruthenium complex and the type/length of the linker between the two units. 23 and 26, two galactose-based diruthenium conjugates, exhibited low IC50 values and reduced effect on HFF viability when applied at 2.5 mu M (23: IC50 = 0.032 mu M/HFF viability 92% and 26: IC50 = 0.153 mu M/HFF viability 97%). Remarkably, compounds 23 and 26 performed significantly better than the corresponding carbohydrate non-modified diruthenium complexes, showing that this type of conjugates are a promising approach for obtaining new antiparasitic compounds with reduced toxicity.
引用
收藏
页数:21
相关论文
共 127 条
  • [1] In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer
    Aird, RE
    Cummings, J
    Ritchie, AA
    Muir, M
    Morris, RE
    Chen, H
    Sadler, PJ
    Jodrell, DI
    [J]. BRITISH JOURNAL OF CANCER, 2002, 86 (10) : 1652 - 1657
  • [2] Drugs in development for toxoplasmosis: advances, challenges, and current status
    Alday, P. Holland
    Doggett, Joseph Stone
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 273 - 293
  • [3] NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry
    Alessio, Enzo
    Messori, Luigi
    [J]. MOLECULES, 2019, 24 (10)
  • [4] Square-Planar vs. Trigonal Bipyramidal Geometry in Pt(II) Complexes Containing Triazole-Based Glucose Ligands as Potential Anticancer Agents
    Annunziata, Alfonso
    Liberti, Davide
    Bedini, Emiliano
    Cucciolito, Maria Elena
    Loreto, Domenico
    Monti, Daria Maria
    Merlino, Antonello
    Ruffo, Francesco
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (16)
  • [5] Five-Coordinate Platinum(II) Compounds as Potential Anticancer Agents
    Annunziata, Alfonso
    Cucciolito, Maria Elena
    Esposito, Roberto
    Ferraro, Giarita
    Monti, Daria Maria
    Merlino, Antonello
    Ruffo, Francesco
    [J]. EUROPEAN JOURNAL OF INORGANIC CHEMISTRY, 2020, 2020 (11-12) : 918 - 929
  • [6] Human toxoplasmosis-Searching for novel chemotherapeutics
    Antczak, Magdalena
    Dzitko, Katarzyna
    Dlugonska, Henryka
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2016, 82 : 677 - 684
  • [7] In Vitro Effects of Novel Ruthenium Complexes in Neospora caninum and Toxoplasma gondii Tachyzoites
    Barna, Fabienne
    Debache, Karim
    Vock, Carsten A.
    Kuester, Tatiana
    Hemphill, Andrew
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (11) : 5747 - 5754
  • [8] Basto AP, 2019, METALLOMICS, V11, P462, DOI [10.1039/c8mt00307f, 10.1039/C8MT00307F]
  • [9] Basto AP, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01031-17, 10.1128/aac.01031-17]
  • [10] Approaching tumour therapy beyond platinum drugs Status of the art and perspectives of ruthenium drug candidates
    Bergamo, A.
    Gaiddon, C.
    Schellens, J. H. M.
    Beijnen, J. H.
    Sava, G.
    [J]. JOURNAL OF INORGANIC BIOCHEMISTRY, 2012, 106 (01) : 90 - 99